Literature DB >> 1688851

Identification of a cartilage-specific promoter within intron 2 of the chick alpha 2(I) collagen gene.

V D Bennett1, S L Adams.   

Abstract

Chick cartilages contain type I collagen mRNAs but do not synthesize type I collagen. The 5' end of the mRNA derived from the alpha 2 type I collagen gene (alpha 2(I] in cartilage differs from the 5' end of the mRNA in cells and tissues that actively synthesize alpha 2(I) collagen. This difference in mRNA structure results from the use of a cartilage-specific transcription start site within intron 2 of the alpha 2(I) collagen gene. The use of the cartilage transcription start site replaces exons 1 and 2 with a 96-base exon contained within intron 2. The resulting transcripts contain several small open reading frames, all of which appear out of frame with the collagen coding sequence. The cartilage form of the mRNA no longer encodes alpha 2(I) collagen, thus explaining the absence of alpha 2(I) collagen in cartilage. Transcription of the alpha 2(I) collagen gene initiates at the previously described (bone/tendon) promoter in prechondrogenic limb mesenchyme, which synthesizes alpha 2(I) collagen. Thus, the cessation of alpha 2(I) collagen synthesis which occurs during differentiation of prechondrogenic mesenchymal cells into chondrocytes apparently results from the switch in promoter utilization from the bone/tendon promoter to the cartilage promoter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688851

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Association of a change in chromatin structure with a tissue-specific switch in transcription start sites in the alpha 2(I) collagen gene.

Authors:  K M Beck; A H Seekamp; G R Askew; Z Mei; C M Farrell; S Wang; L N Lukens
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

3.  Single-strand-DNA-binding factors specifically recognize the pyrimidine element in the chick alpha2(I) collagen gene promoter.

Authors:  D Bayarsaihan; L N Lukens
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

4.  The chick type III collagen gene contains two promoters that are preferentially expressed in different cell types and are separated by over 20 kb of DNA containing 23 exons.

Authors:  Y Zhang; Z Niu; A J Cohen; H D Nah; S L Adams
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

5.  Alpha 2(I) collagen gene expression is up-regulated in quail chondrocytes pretreated with retinoic acid.

Authors:  M Sanchez; E Gionti; A Arcella; G Pontarelli; F De Lorenzo
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Expression of collagen species in a cartilaginous tumor derived from a human osteogenic sarcoma.

Authors:  O Oshima; T Haraki; S Kakuta; Y Kimura; M Nagumo
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

7.  The role of cell adhesion in retinoic acid-induced modulation of chondrocyte phenotype.

Authors:  M Sanchez; A Arcella; G Pontarelli; E Gionti
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

8.  Identification of COL6A2 mutations in progressive myoclonus epilepsy syndrome.

Authors:  Siamak Karkheiran; Catharine E Krebs; Vladimir Makarov; Yalda Nilipour; Benjamin Hubert; Hossein Darvish; Steven Frucht; Gholam Ali Shahidi; Joseph D Buxbaum; Coro Paisán-Ruiz
Journal:  Hum Genet       Date:  2012-11-09       Impact factor: 4.132

Review 9.  Altered proteoglycan gene expression and the tumor stroma.

Authors:  R V Iozzo; I Cohen
Journal:  Experientia       Date:  1993-05-15

10.  Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide.

Authors:  L J Sandell; N Morris; J R Robbins; M B Goldring
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.